New Drug Shows Promise for Treating Rare Brain Tumors - News CenterAn experimental drug, dordaviprone, shows promise in treating H3 K27M-mutant diffuse midline gliomas.The study revealed a 30% positive response rate to the drug in patients with this rare brain tumor subtype.